Published in PLoS One on February 20, 2014
Stem cells in neuroinjury and neurodegenerative disorders: challenges and future neurotherapeutic prospects. Neural Regen Res (2014) 0.91
Role of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesity. Front Neurosci (2015) 0.85
Diabetes and stem cell function. Biomed Res Int (2015) 0.83
Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases. Future Sci OA (2015) 0.81
Abnormal anxiety- and depression-like behaviors in mice lacking both central serotonergic neurons and pancreatic islet cells. Front Behav Neurosci (2014) 0.80
Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease. Biochim Biophys Acta (2016) 0.80
Modulation of hippocampal neural plasticity by glucose-related signaling. Neural Plast (2015) 0.79
The Ticking of the Epigenetic Clock: Antipsychotic Drugs in Old Age. Front Endocrinol (Lausanne) (2016) 0.75
Leptin-dependent neurotoxicity via induction of apoptosis in adult rat neurogenic cells. Front Cell Neurosci (2015) 0.75
Prediabetes and type 2 diabetes implication in central proliferation and neurogenesis. Neural Regen Res (2015) 0.75
Comparative Proteomic Analysis of the Mitochondria-associated ER Membrane (MAM) in a Long-term Type 2 Diabetic Rodent Model. Sci Rep (2017) 0.75
Brain changes in diabetes mellitus patients with gastrointestinal symptoms. World J Diabetes (2016) 0.75
Intranasal insulin reverts central pathology and cognitive impairment in diabetic mother offspring. Mol Neurodegener (2017) 0.75
Mdivi-1 Protects Adult Rat Hippocampal Neural Stem Cells against Palmitate-Induced Oxidative Stress and Apoptosis. Int J Mol Sci (2017) 0.75
Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci U S A (2003) 3.52
Mechanisms of diabetic complications. Physiol Rev (2013) 3.41
The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol (2009) 3.13
Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci (2008) 3.11
Brain structure and obesity. Hum Brain Mapp (2010) 3.04
Hyperinsulinemia and risk of Alzheimer disease. Neurology (2004) 2.87
Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes (2006) 2.77
An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers. J Clin Invest (2012) 2.33
Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc Natl Acad Sci U S A (2010) 1.97
Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia (1996) 1.82
Long-term potentiation enhances neurogenesis in the adult dentate gyrus. J Neurosci (2006) 1.79
Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study. Neurology (2010) 1.64
Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis. BMC Neurosci (2012) 1.60
Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia (2007) 1.59
Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease. Nat Clin Pract Neurol (2006) 1.57
Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin. J Neurosci Res (2008) 1.50
Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. Endocrinology (2009) 1.39
Cerebral cortical thickness in patients with type 2 diabetes. J Neurol Sci (2010) 1.34
Cortical neurogenesis in adult rats after transient middle cerebral artery occlusion. Stroke (2001) 1.30
Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling. J Biol Chem (2007) 1.21
Insulin resistance in the nervous system. Trends Endocrinol Metab (2012) 1.18
Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome. PLoS One (2011) 1.13
Longitudinal study of the effects of a high-fat diet on glucose regulation, hippocampal function, and cerebral insulin sensitivity in C57BL/6 mice. Behav Brain Res (2006) 1.12
Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease. Eur J Pharmacol (2009) 1.10
Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain. J Neurosci Res (2011) 1.02
Increased Aβ production prompts the onset of glucose intolerance and insulin resistance. Am J Physiol Endocrinol Metab (2012) 1.02
Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2. J Neurol Sci (2010) 1.01
Neuroprotective actions of leptin on central and peripheral neurons in vitro. Neuroscience (2008) 0.99
The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease. Brain Res (2012) 0.99
Impaired neurogenesis in adult type-2 diabetic rats. Brain Res (2008) 0.98
Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice. Psychoneuroendocrinology (2013) 0.98
GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid. Eur J Pharmacol (2008) 0.97
Adult mice maintained on a high-fat diet exhibit object location memory deficits and reduced hippocampal SIRT1 gene expression. Neurobiol Learn Mem (2012) 0.97
Leptin action on nonneuronal cells in the CNS: potential clinical applications. Ann N Y Acad Sci (2012) 0.95
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease. Front Biosci (Elite Ed) (2012) 0.92
Rapid β-amyloid deposition and cognitive impairment after cholinergic denervation in APP/PS1 mice. J Neuropathol Exp Neurol (2013) 0.92
Adult hippocampal neurogenesis in aging and Alzheimer's disease. Birth Defects Res C Embryo Today (2010) 0.90
Insulin and ghrelin: peripheral hormones modulating memory and hippocampal function. Curr Opin Pharmacol (2007) 0.90
Dementia, diabetes, Alzheimer's disease, and insulin resistance in the brain: progress, dilemmas, new opportunities, and a hypothesis to tackle intersecting epidemics. J Alzheimers Dis (2011) 0.90
FTY720 normalizes hyperglycemia by stimulating β-cell in vivo regeneration in db/db mice through regulation of cyclin D3 and p57(KIP2). J Biol Chem (2011) 0.88
Insulin resistance in the brain: an old-age or new-age problem? Biochem Pharmacol (2012) 0.87
Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes. Diabetologia (2010) 0.87
Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice. J Cell Mol Med (2012) 0.86
A high fat diet does not exacerbate CA1 injury and cognitive deficits following global ischemia in rats. Brain Res (2008) 0.85
High-fat diet ameliorates neurological deficits caused by defective astrocyte lipid metabolism. FASEB J (2012) 0.83
The adverse impact of type 2 diabetes on brain volume in heart failure. J Clin Exp Neuropsychol (2013) 0.83
Early exposure to a high-fat diet has more drastic consequences on metabolism compared with exposure during adulthood in rats. Horm Metab Res (2012) 0.81
Impaired proliferation of non-parenchymal cells participates in an impairment of liver regeneration in db/db mice. Exp Mol Pathol (2005) 0.76